204Voriconazole Restriction in Addition to Therapeutic Drug Monitoring (TDM) Protocol Results in Optimized Dosing
نویسندگان
چکیده
204. Voriconazole Restriction in Addition to Therapeutic Drug Monitoring (TDM) Protocol Results in Optimized Dosing Natasha Pettit, PharmD; Zhe Han, PharmD; Mildred Vicente, PharmD; Emily Landon, MD; Jennifer Pisano, MD; Allison H. Bartlett, MD, MS; Pharmacy Services, University of Chicago Medicine, Chicago, IL; Pharmacy Services, University of Chicago Medicine, Chicago, IL; Infectious Diseases and Global Health, University of Chicago Medicine, Chicago, IL; Pediatrics (Infectious Diseases), University of Chicago Medicine, Chicago, IL
منابع مشابه
Practical Recommendations for Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology
Despite the fact that pharmacokinetic exposure of kinase inhibitors (KIs) is highly variable and clear relationships exist between exposure and treatment outcomes, fixed dosing is still standard practice. This review aims to summarize the available clinical pharmacokinetic and pharmacodynamic data into practical guidelines for individualized dosing of KIs through therapeutic drug monitoring (TD...
متن کاملVariation in gentamicin and vancomycin dosage and monitoring in UK neonatal units.
BACKGROUND Gentamicin and vancomycin are commonly used in neonatal units for the treatment of life-threatening infections. This study aimed to describe the dosage regimen and the approach to therapeutic drug monitoring (TDM) for both antibiotics in units that participate in a UK neonatal network. METHODS Questionnaires were sent to all units across the Extended Neonatal Network, requesting de...
متن کاملVoriconazole dosing and therapeutic drug monitoring in children: experience from a paediatric tertiary care centre.
OBJECTIVES Therapeutic drug monitoring (TDM) of voriconazole is recommended to achieve trough concentrations of 1-5 mg/L. In children, this is challenging due to age-related variability in voriconazole pharmacokinetics. This study describes our experience with voriconazole, focusing on dosing regimens, dose adjustment and TDM. METHODS We reviewed the medical records of immunocompromised child...
متن کاملTherapeutic Drug Monitoring and Genotypic Screening in the Clinical Use of Voriconazole.
Voriconazole is an antifungal triazole that is the first line agent for treatment of invasive aspergillosis. It is metabolized by CYP2C19, CYP2C9, and CYP3A4 and demonstrates wide interpatient variability in serum concentrations. Polymorphisms in CYP2C19 contribute to variability in voriconazole pharmacokinetics. Here, evidence is examined for the use of voriconazole therapeutic drug monitoring...
متن کاملTherapeutic drug monitoring of the β-lactam antibiotics: what is the evidence and which patients should we be using it for?
Traditional antibiotic dosing was not designed for today's escalating antibiotic resistance, lack of novel antibiotics and growing complexity in patient populations. Dosing that ensures optimal antibiotic exposures should be considered essential to increase the likelihood of effective patient treatment. Given the variability in these exposures across different patients, a 'one-dose-fits-all' ap...
متن کامل